Detalles de la búsqueda
1.
Respiratory recovery trajectories after severe-to-critical COVID-19: a 1-year prospective multicentre study.
Eur Respir J
; 61(4)2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36669777
2.
Anti-PD-(L)1 for KRAS-mutant advanced non-small-cell lung cancers: a meta-analysis of randomized-controlled trials.
Cancer Immunol Immunother
; 71(3): 719-726, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34378081
3.
First-line concomitant EGFR-TKI + chemotherapy versus EGFR-TKI alone for advanced EGFR-mutated NSCLC: a meta-analysis of randomized phase III trials.
Expert Rev Anticancer Ther
; : 1-6, 2024 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38813930
4.
Pleural mesothelioma: a snapshot of emerging drug targets and opportunities for non-surgical therapeutic advancement.
Expert Opin Ther Targets
; 27(11): 1059-1069, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37902459
5.
Outcome following nivolumab treatment in patients with advanced non-small cell lung cancer and comorbid interstitial lung disease in a real-world setting.
Ther Adv Med Oncol
; 15: 17588359231152847, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36743523
6.
Characteristics, management, and healthcare resources of patients with advanced non-small-cell lung cancer surviving 5 years after nivolumab treatment initiation: A national database analysis.
Respir Med Res
; 84: 101051, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37897879
7.
Total Metabolic Tumor Volume on 18F-FDG PET/CT Is a Useful Prognostic Biomarker for Patients with Extensive Small-Cell Lung Cancer Undergoing First-Line Chemo-Immunotherapy.
Cancers (Basel)
; 15(8)2023 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37190152
8.
Real-World Treatment Outcomes of MET Exon14 Skipping in Non-small Cell Lung Cancer: GFPC 03-18 Study.
Target Oncol
; 18(4): 585-591, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37310660
9.
Risk factors for early mortality of lung cancer patients in France: A nationwide analysis.
Cancer Med
; 11(24): 5025-5034, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35567378
10.
Long-term hospital resource utilization and associated costs of care for patients initiating nivolumab in advanced non-small cell lung cancer in France.
J Med Econ
; 25(1): 691-699, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35587018
11.
Machine Learning-Based Analysis of Treatment Sequences Typology in Advanced Non-Small-Cell Lung Cancer Long-Term Survivors Treated With Nivolumab.
JCO Clin Cancer Inform
; 6: e2100108, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35113656
12.
Immune-Checkpoint Inhibitors for Malignant Pleural Mesothelioma: A French, Multicenter, Retrospective Real-World Study.
Cancers (Basel)
; 14(6)2022 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35326648
13.
Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition.
Mol Oncol
; 2022 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36453028
14.
Factors associated with early lung cancer mortality: a systematic review.
Expert Rev Anticancer Ther
; 21(10): 1125-1133, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34121578
15.
Impact on All-Cause and Cardiovascular Mortality Rates of Coronary Artery Calcifications Detected during Organized, Low-Dose, Computed-Tomography Screening for Lung Cancer: Systematic Literature Review and Meta-Analysis.
Cancers (Basel)
; 13(7)2021 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33800614
16.
Factors Associated With Aggressiveness of End-of-Life Care for Lung Cancer Patients and Associated Costs of Care.
Clin Lung Cancer
; 22(3): e320-e328, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32646653
17.
Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapy.
Lung Cancer
; 159: 45-55, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34311344
18.
Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma.
Genome Med
; 13(1): 113, 2021 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34261524
19.
Targeting the MET-Signaling Pathway in Non-Small-Cell Lung Cancer: Evidence to Date.
Onco Targets Ther
; 13: 5691-5706, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32606781
20.
First-line immune-checkpoint inhibitor plus chemotherapy versus chemotherapy alone for extensive-stage small-cell lung cancer: a meta-analysis.
Ther Adv Med Oncol
; 12: 1758835920977137, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33343721